AstraZeneca, Oxford vaccine study allowed to restart in UK

AstraZeneca, Oxford vaccine study allowed to restart in UK

Source: 
BioPharma Dive
snippet: 

The U.K. drugs regulator and an independent committee have agreed to let vaccinations with AstraZeneca and the University of Oxford's experimental coronavirus shot resume at U.K.-based clinical trial sites, less than a week after testing was paused for a safety review.